Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.3699
+0.0199 (5.69%)
At close: Dec 24, 2025, 1:00 PM EST
0.3571
-0.0128 (-3.46%)
After-hours: Dec 24, 2025, 4:31 PM EST

Virax Biolabs Group Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212020
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
00.010.160.01-0.12
Upgrade
Revenue Growth (YoY)
-96.48%-95.95%1727.11%--23.97%
Upgrade
Cost of Revenue
0.050.060.110.01-0.13
Upgrade
Gross Profit
-0.05-0.050.05-0--0.01
Upgrade
Selling, General & Admin
3.394.334.593.551.30.51
Upgrade
Research & Development
2.431.781.562.180.430.12
Upgrade
Operating Expenses
5.826.116.165.731.730.64
Upgrade
Operating Income
-5.87-6.16-6.11-5.73-1.73-0.64
Upgrade
Interest Expense
-0.06-0.06-0.03-0.02-0.02-0.03
Upgrade
Other Non Operating Income (Expenses)
0.010.02-0.02-0-00
Upgrade
EBT Excluding Unusual Items
-5.93-6.2-6.15-5.75-1.75-0.67
Upgrade
Asset Writedown
---0.39---
Upgrade
Legal Settlements
---0.21---
Upgrade
Other Unusual Items
--0.010.29--
Upgrade
Pretax Income
-5.93-6.2-6.74-5.46-1.75-0.67
Upgrade
Income Tax Expense
-0.27-0.14----
Upgrade
Earnings From Continuing Operations
-5.65-6.07-6.74-5.46-1.75-0.67
Upgrade
Minority Interest in Earnings
0.010.010.0100.040.02
Upgrade
Net Income
-5.64-6.06-6.73-5.46-1.71-0.65
Upgrade
Net Income to Common
-5.64-6.06-6.73-5.46-1.71-0.65
Upgrade
Shares Outstanding (Basic)
542110
Upgrade
Shares Outstanding (Diluted)
542110
Upgrade
Shares Change (YoY)
70.75%85.92%88.75%11.15%297.67%130.43%
Upgrade
EPS (Basic)
-1.24-1.62-3.36-5.13-1.79-2.71
Upgrade
EPS (Diluted)
-1.24-1.62-3.36-5.13-1.79-2.71
Upgrade
Free Cash Flow
-5.9-5.17-7.2-4.18-0.81-0.59
Upgrade
Free Cash Flow Per Share
-1.29-1.39-3.59-3.93-0.85-2.45
Upgrade
Gross Margin
--32.34%-15.94%--7.62%
Upgrade
Operating Margin
-196566.68%-97344.76%-3903.69%-66963.68%--520.54%
Upgrade
Profit Margin
-189001.71%-95739.17%-4304.81%-63748.32%--525.75%
Upgrade
Free Cash Flow Margin
-197677.16%-81621.64%-4602.71%-48823.35%--476.65%
Upgrade
EBITDA
-5.56-5.91-6.05---
Upgrade
D&A For EBITDA
0.310.260.05---
Upgrade
EBIT
-5.87-6.16-6.11-5.73-1.73-0.64
Upgrade
Revenue as Reported
-----0.12
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q